Navigation Links
Pharos Innovations Joins Partnership to Fight Chronic Disease
Date:11/25/2008

NORTHFIELD, Ill., Nov. 25 /PRNewswire/ -- Pharos Innovations, a pioneer in assisting clients to achieve next generation clinical and financial performance improvement through a device-free remote monitoring platform, today joined the Partnership to Fight Chronic Disease (PFCD), a coalition of leaders from the healthcare, business, policy and labor communities committed to making chronic disease the key healthcare issue in the new presidential administration.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH086LOGO)

"We are excited to be partnering with an organization that is successfully affecting change in healthcare," said Dr. Randall Williams, CEO of Pharos Innovations. "The PFCD's mission to educate the public, mobilize Americans to call for change and challenge policymakers on health policy changes is in direct alignment with our mission to transform healthcare through a new paradigm of chronic care management delivery."

Pharos joins more than 80 partner organizations in the fight against chronic disease. The PFCD is working to raise awareness of chronic disease nationwide, with a particular focus on the key primary states of Iowa, New Hampshire and South Carolina. The partnership is led by former U.S. Surgeon General Richard H. Carmona, M.D. and Ken Thorpe, PhD, chair of the Rollins School of Public Health at Emory University and a former White House health policy advisor.

"The addition of Pharos strengthens the PFCD in the fight against chronic disease," said Thorpe, executive director of the PFCD. "We look forward to tapping the Pharos team's vast knowledge and substantial resources in making chronic disease the key healthcare issue in the new presidential administration."

Chronic diseases are responsible for seven out of every 10 deaths in the U.S. -- causing more than 1.7 million American deaths every year, according to the Centers for Disease Control and Prevention (CDC). Chronic diseases are also the primary driver of healthcare costs, accounting for more than 75 percent of the $2 trillion dollars spent each year on healthcare in the U.S.

About Pharos Innovations

Founded in 1995, Pharos Innovations assists healthcare providers and payers in achieving next generation clinical and financial performance improvement. An innovative, device-free platform, Tel-Assurance(R), improves care coordination and drives dramatic clinical improvement and cost savings by remotely monitoring patients and averting unnecessary clinical events. Our enabling technologies proactively involve patients in their care and result in the early identification of clinical deterioration.

Tel-Assurance substantially expands the reach, efficiency and effectiveness of clients' current health management programs for complex chronic conditions. The Pharos solution is strongly validated to show measured clinical improvement and financial impact, is the recipient of the prestigious American Heart Association National Outcomes award and was selected for the first ever National Institutes of Health (NIH) sponsored evaluation of remote monitoring interventions. For more information visit http://www.pharosinnovations.com or call (847) 790-7649.

About the PFCD

The Partnership to Fight Chronic Disease (PFCD) is a national coalition of patients, providers, community organizations, business and labor groups, and health policy experts. They are committed to raising awareness of chronic disease and the policies and practices that save lives and reduce health costs through more effective prevention and management of chronic disease.

The mission of the PFCD is to:

-- Educate the public about chronic disease and potential solutions for individuals and communities

-- Mobilize Americans to call for change in how governments, employers, and health institutions approach chronic disease

-- Challenge policymakers on the health policy changes that are necessary to effectively fight chronic disease

Currently, more than 80 advisory board members and partner organizations from across the country have joined the PFCD.

For more information on the partnership, please visit: http://www.fightchronicdisease.org. For more information about Pharos Innovations, please contact Bonni Kaplan, senior director of marketing and communications at Pharos Innovations, at (847) 790-7649 or bkaplan@pharosinnovations.com.

     Contact:  Bonni L. Kaplan
               Pharos Innovations
               847-790-7649
               bkaplan@pharosinnovations.com

'/>"/>
SOURCE Pharos Innovations
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Inverness Medical Innovations Announces Third Quarter 2008 Results
2. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
3. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
4. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
5. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
6. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
7. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
8. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
9. Atrium Innovations to Present at Upcoming 28th Annual Canaccord Adams Global Growth Conference
10. Inverness Medical Innovations Announces Second Quarter 2008 Results
11. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... MA (PRWEB) , ... December 02, 2016 , ... Robots ... Light Event on December 3rd, 2016. The event, which is held on the ... work with helping Americans with Disabilities back into the workplace. Suitable Technologies is partnering ...
(Date:12/2/2016)... December 2, 2016 The immunohistochemistry (IHC) ... at a CAGR of 7.3% during the forecast period of 2016 ... diagnostic laboratories segment accounted for the largest share of immunohistochemistry (IHC) ... , ... global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies ...
(Date:11/30/2016)... ... November 30, 2016 , ... BEI Kimco, a brand ... a flexure design that ensures high alignment accuracy by preventing unwanted shaft rotation. ... suited where extreme precision is required, such as in medical equipment, laboratory instrumentation, ...
(Date:11/30/2016)... , November 30, 2016 ... a few players hold a dominant share in the ... River Laboratories International, Inc., and Merck KGaA, held a ... 2015. Transparency Market Research observes that these companies are ... on development products that are do not require rabbit ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... The report forecasts the biometrics ... a CAGR of 12.28% during the period 2016-2020. ... with inputs from industry experts. The report covers the market landscape ... includes a discussion of the key vendors operating in this market. ...
Breaking Biology News(10 mins):